PEAK6 Investments’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-78,100
Closed -$9.01M 5850
2020
Q4
$9.01M Buy
+78,100
New +$8.75M 0.02% 726
2020
Q1
Sell
-2,100
Closed -$220K 4724
2019
Q4
$220K Sell
2,100
-2,900
-58% -$325K ﹤0.01% 2488
2019
Q3
$575K Buy
5,000
+400
+9% +$60.7K ﹤0.01% 2172
2019
Q2
$793K Buy
+4,600
New +$796K 0.01% 1945
2019
Q1
Sell
-29,400
Closed -$2.86M 4856
2018
Q4
$2.86M Sell
29,400
-102,900
-78% -$13.5M 0.02% 978
2018
Q3
$22.9M Buy
+132,300
New +$19.1M 0.1% 201

Other funds holding GWPH

PEAK6 Investments's GWPH Position: Q1 2021 in Review

PEAK6 Investments sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 3,971 shares — an estimated $458K sold.

PEAK6 Investments first reported a position in GWPH in Q4 2018 and held it in 7 quarters. The position peaked at $2.25M in Q3 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • PEAK6 Investments reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • PEAK6 Investments sold 3,971 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $458K.
  • PEAK6 Investments first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 7 quarters.
  • PEAK6 Investments's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.25M in Q3 2019.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on PEAK6 Investments's 13F filing for Q1 2021, filed 14 May 2021.